Adjuvant radiotherapy in stage I seminoma: Is there a role for further reduction of treatment volume?

Acta Oncologica

Volumn 44, Issue 2, 2005, Pages 142-148

  Bruns, Frank ^a   Bremer, Michael ^a   Meyer, Andreas ^a   Karstens, Johann H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; MALE; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RISK REDUCTION; SEMINOMA; SURGICAL APPROACH;

ADULT; AGED; GERMANY; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RECURRENCE; SEMINOMA; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 17144384745     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860510029581     Document Type: Article

References (32)

1. Jones RH, Vasey PA. Part I: Testicular cancer - management of early disease. Lancet Oncol 2003;4:730-7.
2. Classen J, Hehr T, Bamberg M. Stage I seminoma: From the standard therapy to the risk-adapted treatment strategy. Onkologe 2003;9:973-9.
3. Zagars GK, Ballo MT, Lee AK, Strom SS. Mortality after cure of testicular seminoma. J Clin Oncol 2004;22:640-7.
4. Chang SS, Roth B. Treatment of clinical stage I germ cell tumors. Urology 2002;59:173-9.
5. Fossa SD, Horwich A, Russell JM, Roberts JT, Cullen MH, Hodson NJ, Jones WG, Yosef H, Duchesne GM, Owen JR, Grosch EJ, Chetiyawardana AD, Reed NS, Widmer B, Stenning SP. Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. J Clin Oncol 1999;17:1146-54.
6. Bamberg M, Schmidberger H, Meisner C, Classen J, Souchon R, Weinknecht S, Schorcht J, Walter F, Engenhart-Cabillic R, Schulz U, Born H, Flink M. Radiotherapy for stages I and IIA/B testicular seminoma. Int J Cancer 1999;83:823-7.
7. Donohue JP, Thornhill JA, Foster RS, Rowland RG, Bihrle R. Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): Modifications of technique and impact on ejaculation. J Urol 1993;149:237-43.
8. Foster RS, Donohue JP. Retroperitoneal lymph node dissection for the management of clinical stage I nonseminoma. J Urol 2000;163:1788-92.
9. International Union against Cancer (UICC). Testis (ICD-O C62). In: Sobin LH, Wittekind Ch, editors. TNM classification of malignant tumors, 5th ed. NewYork: Wiley-Liss; 1997. p. 174-9.
10. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-6.
11. Horwich A. Radiotherapy in stage I seminoma of the testis. J Clin Oncol 2004;22:585-8.
12. Kiricuta IC, Sauer J, Bohndorf W. Omission of the pelvic irradiation in stage I testicular seminoma: A study of postorchiectomy paraaortic radiotherapy. Int J Radiat Oncol Biol Phys 1996;35:293-8.
13. Sultanem K, Souhami L, Benk V, Bahary JP, Roman T, Shenouda G, Freeman C. Para-aortic irradiation only appears to be adequate treatment for patients with stage I seminoma of the testis. Int J Radiat Oncol Biol Phys 1998;40:455-9.
14. Logue JP, Harris MA, Livsey JE, Swindell R, Mobarek N, Read G. Short course para-aortic radiation for stage I seminoma of the testis. Int J Radiat Oncol Biol Phys 2003;57:1304-9.
15. Classen J, Souchon R, Hehr T, Bamberg M. Radiotherapy for early stages testicular seminoma: Patterns of care study in Germany. Radiother Oncol 2002;63:179-86.
16. Busch FM, Sayegh ES, Chenault OW Jr. Some uses of lymphangiography in the management of testicular tumors. J Urol 1965;93:490-5.
17. Chiappa S, Uslenghi C, Galli G, Ravasi G, Gonadonna G. Lymphangiography and endolymphatic radiotherapy in testicular tumours. Br J Radiol 1966;39:498-512.
18. Maier JG, Sulak MH, Mittemeyer BT. Seminoma of the testis: Analysis of treatment success and failure. Am J Roentgenol Radium Ther Nucl Med 1968;102:596-602.
19. Ray B, Hajdu SI, Whitmore WF Jr. Distribution of retroperitoneal lymph node metastases in testicular germinal tumors. Cancer 1974;33:340-8.
20. Donohue JP, Zachary JM, Maynard BR. Distribution of nodal metastases in nonseminomatous testis cancer. J Urol 1982;128:315-20.
21. Doerr A, Skinner EC, Skinner DG. Preservation of ejaculation through a modified retroperitoneal lymph node dissection in low stage testis cancer. J Urol 1993;149:1472-4.
22. Fossa SD. Management of clinical stage I seminoma. In: Perry MC, editor. American Society of Clinical Oncology Educational Book, 39th Annual Meeting, Spring 2003. Alexandria (VA): American Society of Clinical Oncology; 2003. p. 131-5.
23. Jones WG, Fossa SD, Mead GM, Roberts JT, Sokal M, Naylor S, Stenning SP. A randomised trial of two radiotherapy schedules in the adjuvant treatment of stage I seminoma (MRC TE18). (Abstr. 572). Eur J Cancer 2001;37(Suppl. 6):S157.
24. Classen J, Dieckmann K, Bamberg M, Souchon R, Kliesch S, Kuehn M, Loy V for the German Testicular Cancer Study Group. Radiotherapy with 16 Gy may fail to eradicate testicular intraepithelial neoplasia: preliminary communication of a dose-reduction trial of the German Testicular Cancer Study Group. Br J Cancer 2003;88:828-31.
25. Jacobsen KD, Olsen DR, Fossa K, Fossa SD. External beam abdominal radiotherapy in patients with seminoma stage I: Field type, testicular dose, and spermatogenesis. Int J Radiat Oncol Biol Phys 1997;38:95-102.
26. Warde P, Specht L, Horwich A, Oliver T, Panzarella T, Gospodarowicz M, von der Maase H. Prognostic factors for relapse in stage I seminoma managed by surveillance: A pooled analysis. J Clin Oncol 2002;20:4448-52.
27. Cullen MH, Stenning SP, Parkinson MC, et al. Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: A Medical Research Council report. J Clin Oncol 1996;14:1106-13.
28. Oliver RT, Edmonds PM, Ong JY, Ostrowski MJ, Jackson AW, Bailie-Johnson H, Williams MV, Wiltshire CR, Mott T, Pratt WR, et al. Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: Should it be tested in a randomized trial against radiotherapy? Int J Radiat Oncol Biol Phys 1994;29:3-8.
29. Dieckmann KP, Bruggeboes B, Pichlmeier U, Kuster J, Mullerleile U, Bartels H. Adjuvant treatment of clinical stage I seminoma: Is a single course of carboplatin sufficient? Urology 2000;55:102-6.
30. Steiner H, Hold L, Wirtenberger W Long-term experience with carboplatin monotherapy for clinical stage I seminoma: A retrospective single center study. Urology 2000;60:324-8.
31. Oliver RT, Mason M, Von der Masse H, Stenning SP, Kirk S, Rustin GJ, Mead GM, Ell PJJ. A randomised comparison of single agent carboplatin with radiotherapy in the adjuvant treatment of stage I seminoma of the testis, following orchidectomy: MRC TE19/EORTC 30982. (Abstr. 4517). 2004 ASCO Annual Meeting jProceedings. J Clin Oncol 2004;22(14S):385.
32. Schmoll HJ, Souchon R, Krege S, Albers P, Beyer J, Kollmannsberger C, Fossa SD, et al. European consensus on diagnosis and treatment of germ cell cancer: A report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004;15:1377-99.